foxo4-dri senolytic peptide FOXO4-DRI: Human Trial Status, Cancer Research & Data The disordered p53 transactivation domain
The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications FOXO4 DRI Peptide Potential Interactions with Aged Cell Cultures FOXO4 DRI Peptide Dosing Guide: Senolytic Peptide Protocol (June 2026) FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway PMC FOXO4 DRI For Sale (10mg) Core Peptides
Pay in 4 interest-free payments of $7.09 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8




